Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)
Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies in the People's Republic of China.
4.68-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-40.7%
The outlook
Jacobio Pharmaceuticals Group Co., Ltd. currently reads as leaning bearish based on below its 50- & 200-day averages, 9% of the way from its 52-week low to high, avg target +111% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range9% of the way from its 52-week low to high
Price targetAvg target +111% vs current price
Analyst price target
~12-month · 2 analysts9.87average target+110.9% vs now
Now 4.68
Low 9.20High 10.54
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.66B
52-wk high
11.80
52-wk low
3.98
50-day avg
4.81
200-day avg
6.45
Trailing P/E
—